Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Pyridine → 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2-yl pivalate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Pyridine | HCID 1049 | — |
| 반응물 | Pivaloyl chloride | HCID 62493 | — |
| 반응물 | Dehydroaripiprazole | HCID 10114519 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2-yl pivalate | HCID 56596935 | — |
반응 단계
To a solution of dehydro-aripiprazole (1.2 g, 2.7 mmol) in dichloromethane (30 mL) was added pyridine (1 mL), followed by pivaloyl chloride (0.66 mL, 5.4 mmol). The reaction mixture was stirred for 20 hours, then washed with water and dried over MgSO4. After evaporation the residue was co-evaporated with toluene and then further purified on silica eluting with ethyl acetate. After evaporation of the product containing fraction, Compound-316 (0.53 g) was obtained as a colourless oil.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09072788B2 |
| 출처 데이터셋 | uspto-grants-2015_07 |
| ORD ID | ord-35828f4ceb1d43778f2eccd456761685 |
| 출처 메모 | uspto-grants-2015_07 |